Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | CASP7 | P55210 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.51 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | CDC25B | P30305 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.49 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.49 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.49 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30198949 | 1.00 | TDP1 (0.60) | TDP1ALDH1A1MAPK1CASP7L3MBTL1 | |
| Hydrochloric Acid SCHEMBL28855008 | 0.98 | TDP1 (0.58) | TDP1ALDH1A1MAPK1CASP7L3MBTL1 | |
| Water SCHEMBL27730559 | 0.98 | TDP1 (0.58) | TDP1ALDH1A1MAPK1CASP7L3MBTL1 | |
| Formic Acid SCHEMBL27944357 | 0.91 | MEN1 (0.54) | TDP1ALDH1A1MAPK1CASP7L3MBTL1 | |
| Carbamic Acid SCHEMBL29194239 | 0.89 | KMT2A (0.56) | TDP1ALDH1A1MAPK1CASP7L3MBTL1 | |
| Anisole SCHEMBL25289182 | 0.86 | SMN1; SMN2 (0.52) | TDP1ALDH1A1MAPK1CASP7L3MBTL1 | |
| SCHEMBL29494077 | 0.86 | MAPK1 (0.55) | TDP1ALDH1A1MAPK1CASP7L3MBTL1 | |
| SCHEMBL27587754 | 0.83 | ALDH1A1 (0.48) | TDP1ALDH1A1MAPK1CASP7L3MBTL1 | |
| Isophthalic Acid SCHEMBL28045436 | 0.82 | HCAR3 (0.68) | TDP1ALDH1A1MAPK1L3MBTL1MEN1 | |
| SCHEMBL397773 | 0.82 | MAPK1 (0.77) | TDP1ALDH1A1MAPK1CASP7L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 656 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662484-A1 | MULTISENSOR ARRAYS, MULTISENSOR SYSTEMS AND RELATED METHODS | Linxens Holding (FR) | 2025-12-17 | — | — | EP | claimed |
| CN-118746632-A | Method for simultaneously detecting aromatic nitro compounds and aromatic nitrogen amide compounds | 淄博高新技术产业开发区生物医药研究院 | 2024-10-08 | — | — | CN | claimed |
| WO-2024165881-A1 | MULTISENSOR ARRAYS, MULTISENSOR SYSTEMS AND RELATED METHODS | LINXENS HOLDING (FR) | 2024-08-15 | — | — | WO | claimed |
| US-11834383-B2 | Energetic feedstock for additive manufacturing | LYNNTECH, INC. (US) | 2023-12-05 | — | — | US | claimed |
| US-20230084927-A1 | GLUCOSE UPTAKE INHIBITORS AND USES THEREOF | METABOMED LTD. (IL) | 2023-03-16 | — | — | US | claimed |
| EP-4058027-A1 | GLUCOSE UPTAKE INHIBITORS AND USES THEREOF | Metabomed Ltd (IL) | 2022-09-21 | — | — | EP | claimed |
| US-20210276931-A1 | Energetic Feedstock for Additive Manufacturing | LYNNTECH, INC. | 2021-09-09 | — | — | US | claimed |
| WO-2021095032-A1 | GLUCOSE UPTAKE INHIBITORS AND USES THEREOF | METABOMED LTD (IL) | 2021-05-20 | — | — | WO | claimed |
| CN-109467495-B | Solid propellant with polyether-butyl hydroxyl block polymer as adhesive | 湖北航天化学技术研究所 | 2020-10-30 | — | — | CN | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| US-6169204-B1 | DISSOLVING THE N-METHYL-O-PHENYLENEDIAMINE IN A FIRST SOLVENT, REACTING THE DISSOLVED N-METHYL-O-PHENYLENEDIAMINE WITH CRYSTALLINE PHOSPHORIC ACID OR PHOSPHORIC ACID DISSOLVED IN SECOND SOLVENT TO FORM PHOSPHORIC SALT | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-01-02 | — | — | US | claimed |
| WO-2000063156-A1 | PHOSPHORIC ACID SALT OF AN AROMATIC DIAMINE | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-10-26 | — | — | WO | claimed |
| US-6126763-A | A MINIMUM SMOKE GAS GENERATING PROPELLANT COMPRISING, AN OXIDIZER, A PLASTICIZER BLEND, A BINDER WHICH INCLUDES CAPROLACTONE POLYOL, AND POLYGLYCOL ADIPATE, A STABILIZER, A CURATIVE, AND BALLISTIC STABILIZERS | ATLANTIC RESEARCH CORPORATION (US) | 2000-10-03 | — | — | US | claimed |
| US-6066213-A | LEAD CITRATE AND A HIGH ENERGY PLASTICIZER BLEND INCLUDING 1,2,4-BUTANETRIOL TRINITRATE (BTTN) AND DIETHYLENEGLYCOL DINITRATE (DEGDN) | ATLANTIC RESEARCH CORPORATION (US) | 2000-05-23 | — | — | US | claimed |
| EP-0705808-B1 | Propellant based on phase-stabilized ammonium nitrate | FRAUNHOFER GES FORSCHUNG (DE) | 1997-10-29 | — | — | EP | claimed |
| EP-0705809-B1 | Propelland based on phase-stabilized ammonium nitrate | FRAUNHOFER GES FORSCHUNG (DE) | 1997-07-02 | — | — | EP | claimed |
| EP-0705808-A1 | Propellant based on phase-stabilized ammonium nitrate | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1996-04-10 | — | — | EP | claimed |
| EP-0705809-A1 | Propelland based on phase-stabilized ammonium nitrate | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1996-04-10 | — | — | EP | claimed |
| US-4169853-A | HYDROGENATION, CATALYST SELECTIVITY | TEXACO DEVELOPMENT CORPORATION (US) | 1979-10-02 | — | — | US | claimed |
| US-4076537-A | Light-sensitive materials containing organo tellurium or selenium compounds and sensitizers | FUJI PHOTO FILM CO., LTD. (JA) | 1978-02-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230084927-A1 | GLUCOSE UPTAKE INHIBITORS AND USES THEREOF | SLC2A4, SLC2A1, SLC2A2 | TDP1 3667/4885ALDH1A1 1014/4885MAPK1 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.